Safety and Immunogenicity of a Heterologous Boost with a Recombinant Vaccine, NVSI-06-07, in the Inactivated Vaccine Recipients from UAE: a Phase 2 Randomised, Double-Blinded, Controlled Clinical Trial
semanticscholar(2022)
Key words
Vaccines,Corona Virus
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined